Steward Partners Investment Advisory LLC Decreases Stock Position in Teladoc Health, Inc. (NYSE:TDOC)

Steward Partners Investment Advisory LLC lessened its stake in shares of Teladoc Health, Inc. (NYSE:TDOCGet Rating) by 16.5% during the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 4,111 shares of the health services provider’s stock after selling 811 shares during the period. Steward Partners Investment Advisory LLC’s holdings in Teladoc Health were worth $297,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. ARK Investment Management LLC raised its holdings in Teladoc Health by 2.9% during the 1st quarter. ARK Investment Management LLC now owns 19,466,931 shares of the health services provider’s stock valued at $1,404,150,000 after buying an additional 544,733 shares during the period. Sumitomo Mitsui Trust Holdings Inc. increased its stake in Teladoc Health by 17.1% in the fourth quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 9,140,808 shares of the health services provider’s stock worth $839,309,000 after purchasing an additional 1,336,508 shares during the period. Nikko Asset Management Americas Inc. increased its stake in Teladoc Health by 18.2% in the fourth quarter. Nikko Asset Management Americas Inc. now owns 8,755,058 shares of the health services provider’s stock worth $809,843,000 after purchasing an additional 1,349,776 shares during the period. Kinnevik AB publ purchased a new stake in Teladoc Health in the fourth quarter worth $458,235,000. Finally, Discovery Value Fund increased its stake in Teladoc Health by 0.5% in the fourth quarter. Discovery Value Fund now owns 2,163,209 shares of the health services provider’s stock worth $198,626,000 after purchasing an additional 11,410 shares during the period. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Teladoc Health Price Performance

Shares of NYSE TDOC opened at $36.85 on Friday. The company has a debt-to-equity ratio of 0.17, a quick ratio of 3.71 and a current ratio of 3.94. The company has a market cap of $5.94 billion, a PE ratio of -0.86 and a beta of 0.79. The business has a 50-day simple moving average of $35.94 and a two-hundred day simple moving average of $53.67. Teladoc Health, Inc. has a fifty-two week low of $27.38 and a fifty-two week high of $156.82.

Teladoc Health (NYSE:TDOCGet Rating) last released its earnings results on Wednesday, April 27th. The health services provider reported ($0.47) EPS for the quarter, topping analysts’ consensus estimates of ($0.55) by $0.08. Teladoc Health had a negative return on equity of 2.12% and a negative net margin of 321.94%. The firm had revenue of $565.35 million during the quarter, compared to the consensus estimate of $568.91 million. During the same quarter in the previous year, the company posted $0.13 earnings per share. As a group, equities analysts expect that Teladoc Health, Inc. will post -2.05 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have weighed in on TDOC. Robert W. Baird reduced their target price on Teladoc Health from $72.00 to $64.00 in a research note on Wednesday, April 27th. Barclays reduced their target price on Teladoc Health from $42.00 to $40.00 and set a “maintains” rating on the stock in a research note on Thursday. William Blair lowered Teladoc Health from an “outperform” rating to a “market perform” rating in a research note on Thursday, April 28th. Craig Hallum reduced their target price on Teladoc Health from $67.00 to $30.00 in a research note on Thursday, April 28th. Finally, Deutsche Bank Aktiengesellschaft cut their price target on Teladoc Health from $44.00 to $34.00 in a research note on Friday. One equities research analyst has rated the stock with a sell rating, nineteen have given a hold rating and seven have given a buy rating to the stock. According to MarketBeat, Teladoc Health currently has an average rating of “Hold” and an average price target of $79.07.

Insider Buying and Selling

In related news, SVP Daniel Trencher sold 1,000 shares of Teladoc Health stock in a transaction dated Monday, July 18th. The stock was sold at an average price of $41.12, for a total transaction of $41,120.00. Following the completion of the sale, the senior vice president now owns 27,408 shares of the company’s stock, valued at $1,127,016.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, SVP Daniel Trencher sold 1,000 shares of Teladoc Health stock in a transaction dated Monday, July 18th. The stock was sold at an average price of $41.12, for a total transaction of $41,120.00. Following the completion of the sale, the senior vice president now owns 27,408 shares of the company’s stock, valued at $1,127,016.96. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Mala Murthy sold 4,053 shares of Teladoc Health stock in a transaction that occurred on Monday, June 27th. The shares were sold at an average price of $37.32, for a total value of $151,257.96. Following the transaction, the chief financial officer now owns 27,295 shares of the company’s stock, valued at $1,018,649.40. The disclosure for this sale can be found here. Insiders sold 6,053 shares of company stock valued at $221,498 over the last quarter. 1.55% of the stock is currently owned by company insiders.

About Teladoc Health

(Get Rating)

Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions.

Featured Articles

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOCGet Rating).

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.